![Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer | British Journal of Cancer Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-020-0901-z/MediaObjects/41416_2020_901_Fig1_HTML.png)
Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer | British Journal of Cancer
![Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-21048-y/MediaObjects/41598_2018_21048_Fig1_HTML.jpg)
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
![Multivariate analysis for OS according to tumor markers CA15-3 and CEA.... | Download Scientific Diagram Multivariate analysis for OS according to tumor markers CA15-3 and CEA.... | Download Scientific Diagram](https://www.researchgate.net/publication/334496413/figure/fig2/AS:961367536312328@1606219290978/Multivariate-analysis-for-OS-according-to-tumor-markers-CA15-3-and-CEA-a-Luminal-A.png)
Multivariate analysis for OS according to tumor markers CA15-3 and CEA.... | Download Scientific Diagram
![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-gr2.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
![Changes in tumor markers during the course of the treatment. CEA and... | Download Scientific Diagram Changes in tumor markers during the course of the treatment. CEA and... | Download Scientific Diagram](https://www.researchgate.net/publication/337953365/figure/fig3/AS:836910339604480@1576546382023/Changes-in-tumor-markers-during-the-course-of-the-treatment-CEA-and-AFP-sharply.png)
Changes in tumor markers during the course of the treatment. CEA and... | Download Scientific Diagram
![Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung - Journal of Thoracic Oncology Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e428395a-6575-43f1-bbb1-57200247edee/gr1_lrg.jpg)
Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung - Journal of Thoracic Oncology
![CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-021-01431-9/MediaObjects/41416_2021_1431_Fig1_HTML.png)
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer
![Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy - Annals of Oncology Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/0855c376-0122-4b4e-8761-6754643d6045/gr1.jpg)
Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy - Annals of Oncology
![Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy | SpringerLink Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10147-020-01684-z/MediaObjects/10147_2020_1684_Fig1_HTML.png)
Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy | SpringerLink
![The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ] The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2019/7433/1/fig-2-full.png)
The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer [PeerJ]
![PDF) Tumor markers cancer antigen 15.3, carcinoembryonic antigen, and tissue polypeptide antigen for monitoring metastatic breast cancer during first-line chemotherapy and follow-up PDF) Tumor markers cancer antigen 15.3, carcinoembryonic antigen, and tissue polypeptide antigen for monitoring metastatic breast cancer during first-line chemotherapy and follow-up](https://i1.rgstatic.net/publication/14594228_Tumor_markers_cancer_antigen_153_carcinoembryonic_antigen_and_tissue_polypeptide_antigen_for_monitoring_metastatic_breast_cancer_during_first-line_chemotherapy_and_follow-up/links/5821bea608ae5385869fdebb/largepreview.png)
PDF) Tumor markers cancer antigen 15.3, carcinoembryonic antigen, and tissue polypeptide antigen for monitoring metastatic breast cancer during first-line chemotherapy and follow-up
![PDF) Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer PDF) Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer](https://i1.rgstatic.net/publication/235603976_Sensitivity_of_CA_15-3_CEA_and_serum_HER2_in_the_early_detection_of_recurrence_of_breast_cancer/links/562e166508ae518e3482a444/largepreview.png)
PDF) Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer
![The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-4987-0/MediaObjects/12885_2018_4987_Fig1_HTML.png)